W
#Novartis #Pharmaceuticals #Oncology
www.wsj.com
Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion
Novartis is paying $2 billion upfront and up to $1 billion subject to targets to acquire Pikavation Therapeutics. fabrice coffrini/Agence France-Presse/Getty Images
Novartis NOVN -1.
#Diabetes #Generics #Pharmaceuticals
ca.finance.yahoo.com
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India
HYDERABAD, March 19 (Reuters) - India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires this week, triggering a wave of cheaper generics from local drugmakers and worries about uneven oversight in an overcrowded market.
#MiddleEastConflict #HealthcareSupplyChain #Pharmaceuticals
ca.finance.yahoo.com
Analysis-Middle East war disrupts pharma air routes, risks cancer drugs supply
LONDON, March 16 (Reuters) - War in the Middle East is disrupting the flow of critical medicines to the Gulf, imperilling supply routes for cancer drugs and other treatments that require refrigeration and forcing companies to reroute flights and find overland access into the region, industry executives said.
#ArtificialIntelligence #Pharmaceuticals #DrugManufacturing
www.forbes.com
How Lilly Used AI To Crank Up Production Of Its Popular GLP-1s
Forget the drug discovery hype. Here's how the world's largest pharma company is seeing a payoff from AI right now.
here's been huge hype around AI's potential for drug discovery.
#DrugPrices #Healthcare #Pharmaceuticals
www.newsweek.com
List of medications seeing major price changes in 2026
A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of the manufacturers that made deals with the Trump administration to lower prices.
#HenriettaLacks #MedicalEthics #Pharmaceuticals
us.cnn.com
Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine | CNN
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine.
#Pharmaceuticals #WeightLoss #DiabetesMedication
us.cnn.com
Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027 | CNN
Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027.
#OverTheCounter #Pharmaceuticals #FDA
www.cnbc.com
FDA chief Marty Makary says 'everything should be over-the-counter' unless drug is unsafe or addictive
FDA's Marty Makary: Everything should be over-the-counter unless it's unsafe or requires monitoring
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes "everything should be over-the-counter" unless a drug is unsafe, addictive or requires monitoring - doubling down on a push that some in the pharmaceutical industry have questioned.
#Pharmaceuticals #Onshoring #AffordableMedicine
www.breitbart.com
Exclusive -- Secretary Lutnick: $400 Billion of Pharma Manufacturing Coming Home to America
Four hundred billion dollars of pharmaceutical manufacturing is headed to the U. S. thanks to the Trump administration's policies, Commerce Secretary Howard Lutnick said Wednesday at a policy discussion hosted by Breitbart News.
#HealthCare #ConsumerSavings #Pharmaceuticals
www.cbsnews.com
TrumpRx: See the 43 drugs available on the Trump administration's new discounted drug site
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics.
#AstraZeneca #pharmaceuticals #cancerresearch
uk.finance.yahoo.com
AstraZeneca profits jump by 40% amid strong demand for cancer drugs
Drugs giant AstraZeneca has notched up a 40% surge in annual profits and forecast further growth in earnings over the year ahead as it continues to put faith in strong demand for its cancer treatments.
